Cystic fibrosis drug needs to be cheaper to be cost-effective, analysis finds

Cystic fibrosis drug needs to be cheaper to be cost-effective, analysis finds

STAT Plus: Vertex’s new cystic fibrosis drug needs to be far cheaper to be cost-effective, analysis finds

By ED SILVERMAN

BILL SIKES/AP

Vertex's groundbreaking cystic fibrosis drug Trikafta needs to have a far lower price to be cost-effective, according to a new analysis.

READ MORE